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Abstract
Background: To date, no prospective epidemiological data
are available, particularly in women, on mean leukocyte telo-
mere length as a risk predictor.
Methods: Using leukocyte DNA samples collected at base-
line in a prospective cohort of over 28,000 initially healthy
women, we examined the relationship between mean leu-
kocyte telomere repeat copy number to single gene copy
number (TSR) in 134 incident cases of colorectal carcinoma
(CRC), and 357 matched controls; all were Caucasian.
Results: The observed loge-transformed TSRs were similar
between cases and controls (ps0.79). Using an adjusted
analysis, we found no evidence for an association of the loge-
TSRs with CRC risk wadjusted odds ratio (OR)s0.943, 95%
confidence interval (CI)s0.647–1.376, ps0.762x. Stratified
analysis by median follow-up time, or postmenopausal status
also showed similar null findings.
Conclusions: In concordance with our previous findings in
Caucasian men, the present study in Caucasian women found
no evidence for an association of mean leukocyte telomere
length with risk of incident CRC, further suggesting that leu-
kocyte telomere length may not be a useful indicator for risk
assessment.
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Introduction
Telomeres are tandem repeats of DNA sequences (special
chromatin structures) located at the ends of eukaryotic chro-
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mosomes. They are believed to protect the telomeric regions
from recombination and degradation, thus avoiding chro-
mosomal instability and cell senescence (1, 2). Genomic
instability is a hallmark of tumorogenesis, and is widely
believed to play an important role in development of cancer,
including colorectal carcinoma (CRC) (1, 3). Recent studies
have implicated telomere length shortening as an independ-
ent marker for the progression and/or prognosis of CRC
(4–11). This is based on the comparison of paired cancerous
and adjacent non-cancerous tissue specimens from the same
individuals. Using a nested case control approach, we recent-
ly examined the relationship between leukocyte telomere
length and incident CRC in Caucasian men, and found no
evidence for an association (12). In addition, both experi-
mental and human studies have shown longer telomeres in
adult females than in adult males (13–17). The gender dif-
ference in relation to leukocyte telomere length may reflect
true, differential biological responses (and environmental/
lifestyle factors) to oxidative stress (18–21). Owing to the
gender specific phenomenon, along with the fact that, to
date, no prospective epidemiological studies, particularly in
women, on the relationship of leukocyte telomere length as
a risk predictor with incident CRC are available, the present
study was performed to further examine the possible asso-
ciation of peripheral blood leukocyte (PBL) telomere length
with risk of incident CRC using a nested, matched case con-




We conducted a case control study nested within the WHS cohort,
a completed randomized, double blinded, placebo controlled trial
of aspirin and vitamin E in the primary prevention of cancer and
cardiovascular disease (22–24). Beginning in 1993, 39,876 US
female health professionals, predominantly Caucasian ()94%),
aged G45 years and free of cancer or cardiovascular disease,
enrolled in the study and completed a baseline questionnaire about
their medical history and potential risk factors for CRC. Blood sam-
ples were collected from 28,345 (71%) women before randomiza-
tion. The baseline characteristics of women who provided blood
were largely similar to those who did not (25).
The present study consisted of 134 confirmed cases of incident
CRC as of December 2005, and 357 healthy controls matched by
age ("2 years) and length of follow-up since randomization; all
cases and controls were Caucasian. To increase the statistical power,
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Table 1 Baseline characteristics of study participants.
Controls Cases p-Valuea
(ns357) (ns134)
Age, years 60.66"8.63 60.10"8.68 0.53




Body mass index, kg/m2 25.87"4.94 26.18"5.56 0.55
Alcohol use, % 0.30
Never 41.18 45.52
)0–-15 g/day 51.26 44.03





Aspirin use, % 52.38 46.27 0.23
b-Carotene use, % 48.74 51.49 0.59
Median length of follow-up since randomization, yearsb 5.84 w4.04–5.00x 5.80 w3.68–7.58x 0.33
Postmenopausal, % 84.31 84.33 0.99
Current HRT use, % 42.58 35.07 0.28
Polyps, % 1.96 3.73 0.26
Cancer site, % –
Colon – 76.34
Rectum – 23.66
Family history of CRC, % 10.92 11.19 0.93
Loge-transformed TSR 4.51"0.77 4.49"0.78 0.79
Mean"SD unless otherwise stated. aContinuous and categorical variables were tested by non-paired t-test and x2 analysis, respectively.
bMedian and interquartile range. CRC, colorectal carcinoma; HRT, hormone replacement therapy; TSR, telomere repeat copy number to
single gene copy number.
we attempted to match up to three controls for each case. Median
length of follow-up since randomization for the cases was 5.80 years
(interquartile range: 3.68–7.58). The present study was approved
by the Brigham and Women’s Hospital Institutional Review Board
for Human Subjects Research.
Mean telomere length determination
Unified quantitative polymerase chain reaction (qPCR) assay
Genomic DNA was extracted from whole blood using the QIAmp
Spin Column protocol (Qiagen, Chatsworth, CA, USA). Telomere
length was determined using a previously described, qPCR protocol
(26). In brief, two master mixes of PCR reagents were prepared,
one for telomere reaction and one for single copy gene reaction
(36B4 on chromosome 12). The telomere repeat copy number to
single gene copy number (TSR) ratio was determined with an ABI
7900HT Sequence Detection System (Applied Biosystems, Foster
City, CA, USA) in a 384-well format using the following PCR pro-
tocol: 958C for 15 min to activate Taq-polymerase; 40 cycles of
denaturation at 958C for 15 s, and annealing-extension at 548C for
2 min. The primer sequences used were described elsewhere (26,
27). All samples for both the telomere and single-copy gene ampli-
fications were performed in duplicate on the same 384-well plate.
Ct-value assignment was carried out by two independent observers,
and if necessary, a complete re-amplification was performed. Dupli-
cates of a no-template control were included in each run. Melting
(dissociation) curve analysis was performed on every run to verify
specificity and identity of the PCR products. The Ct values gener-
ated were used to calculate the TSR for each sample using the
equation: T/Ss2–DCt (where DCtsCtsingle-copy gene–Cttelomere).
Results were scored blinded as to case-control status.
Statistical analysis
The observed TSRs had a skewed distribution, and thus the data
were loge-transformed. Spearman’s correlation analysis was used to
assess the association of age, current smoking, body mass index
(BMI), alcohol use, exercise, and current hormone replacement ther-
apy (HRT) use on TSRs amongst all participants. The loge-TSRs
between cases and controls were compared using the non-paired t-
test. The risk ratio of CRC associated with loge-TSRs was calculated
using conditional logistic regression analysis, adjusting for age, and
smoking status, and further controlling for randomized treatment
assignment, BMI, alcohol use, exercise, presence of colorectal
polyps, postmenopausal status and HRT use. All analyses were
performed using SAS 9.1 package (SAS Institute Inc, Cary, NC,
USA). A two-tailed p-value of -0.05 was considered statistically
significant.
Results
The baseline characteristics of the study participants are
shown in Table 1. No significant correlation was found
between the observed TSRs and the clinical/demographic
parameters evaluated (Table 2). The observed TSRs were
similar between cases and controls (ps0.790; Table 1). In
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Table 2 Spearman correlation analysis of TSR with several base-




Body mass indexb 0.030 0.506
Current smokingb 0.017 0.713
Alcohol useb –0.056 0.220
Exerciseb –0.029 0.520
Current HRT useb –0.014 0.753
aSpearman partial correlation coefficients adjusted for case-control
status. bSpearman partial correlation coefficients adjusted for age
and case-control status. TSR, telomere repeat copy number to sin-
gle gene copy number; HT, hormone therapy.
Table 3 Conditional logistic regression analysis of shortening of loge-transformed TSR.
Colorectal Crude Adjusted
carcinoma
OR 95% CI p-Value OR 95% CI p-Value
All participants 0.982 0.692–1.393 0.921 0.943 0.647–1.376 0.762
Postmenopausal 1.005 0.688–1.468 0.979 1.013 0.668–1.534 0.952
women only
Crudesadjusting for age, and smoking status. Adjustedsfurther controlling for body mass index, randomized treatment group, presence
of colorectal polyps, alcohol use, exercise, postmenopausal status (if applicable), and hormone therapy use. TSR, telomere repeat copy
number to single gene copy number.
addition, no association between mean loge-TSRs and risk
of incident CRC was found in the regression analysis wadjust-
ed odds ratio (OR)s0.943, 95% confidence interval
(CI)s0.647–1.376, ps0.762; Table 3x. Regression analysis
limited to postmenopausal female participants (adjusted
ORs1.013, 95% CIs0.668–1.534, ps0.952; Table 3), and
stratified analysis by median follow-up time since randomi-
zation (data not shown) was also performed, again showing
null findings. Further regression analysis using a quartile
comparison approach of loge-TSR again found null findings
(data not shown). The coefficients of variation of the telo-
mere, single-gene, and TSR duplicate assays were all -3%.
Discussion
To the best of our knowledge, the present nested, matched
case control study is the first to examine the relationship
between mean leukocyte telomere length and risk of incident
CRC in women. We found no evidence for an association,
and the null findings in Caucasian women support our recent
findings in Caucasian men using a similar study design (12).
Recent studies have shown telomere length shortening as
an independent marker for the progression and/or prognosis
of CRC (4–11). However, these studies used colonocyte-
telomere length measurements from paired cancerous and
non-cancerous tissue specimens from the same individuals,
as opposed to PBL. Also, it has been shown that telomere
dynamics in colonocytes differ from other tissues including
PBL (10, 28), due partly to the local dynamics of telomere-
telomerase complex in cell proliferation (8), and exposure/
responses to oxidative damage (29) in persons with CRC.
Moreover, in a case control study by Risques et al. (30)
examining telomere length from various types of tissue
(including circulating leukocytes) in ulcerative colitis (UC),
a chronic inflammatory condition that predisposes to CRC,
a modest shortening in leukocytes from UC subjects
(ns102) compared to controls (ns45) (ps0.046) was
found. The authors hypothesized that the moderate shorten-
ing of leukocyte telomeres was due to its proliferative prop-
erties and frequent travel through the inflamed colon. The
potential involvement of leukocyte telomere biology in risk
of CRC requires further investigation in future large pro-
spective studies.
The nature of the present investigation in which determi-
nation of case status was based solely on the subsequent
development of disease rather than on any arbitrary selection
criteria designed by the investigators, greatly reduce the pos-
sibility of bias and confounders. However, our study popu-
lation consisted of Caucasian females only, so the data may
not be applicable to other ethnic groups, non-Caucasian men,
or populations with different socioeconomic backgrounds.
The present null findings could be partly due to bias from
different environmental/lifestyle factors obtained for the
present female population compared to those in our previous
male population (12), or due to chance. Furthermore, in con-
trast to our previous observation in men (12), no correlation
between leukocyte telomere length and age was observed.
This may partly be due to the present (age) matching selec-
tion criteria and the modest sample size of our control par-
ticipants, and the inability to obtain enough variability in age
to detect a relationship.
Based on the present sample size, assuming 80% power
at an a of 0.05, we had the ability to detect a difference in
the loge-transformed TSR of -–0.218 or )0.218 between
cases and controls. Thus, the present study may have limited
power to detect a true, small-to-moderate difference of telo-
mere length between cases and controls.
In conclusion, the present prospective, nested case control
study of Caucasian women from the US found no evidence
for an association between mean leukocyte telomere length
with risk of incident CRC. In concordance with our previous
findings in a prospective, nested case-control study of mid-
dle-aged US white men, the present findings further suggest
that leukocyte telomere length may not be a useful predictor
for risk assessment of CRC.
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